Deterioration of kidney function by high doses of co-trimoxazole in man.
High doses of co-trimoxazole in a patient with Pneumocystis carinii and impaired kidney function (creatinine clearance 10 ml/min) resulted in a declining renal clearance of the drug but did not affect the average creatinine clearance. The renal clearance of sulfamethoxazole and its metabolites 5-hydroxy-, N4-acetyl-, N4-acetyl-5-hydroxysulfamethoxazole decreased 80%, while the renal clearance of trimethoprim decreased 60%. The renal clearance of all compounds was evidently dependent on urine flow. The observed phenomena may be explained by the assumption that crystalluria occurred, obstructing kidney tubules. The crystalluria effect can be reversed by cessation of the drug or by lowering its dosage.
D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007700:Kinetics; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole